ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Psychedelic Science 2025 Presents Cinematheque: A Celebration of Psychedelic Cinema

• Four-Day Film Program to Showcase Visionary Storytelling, Healing Journeys, Consciousness Exploration, Sacred Stories, and the Expanding Role of Psychedelics in Culture and Science

• Featured Films Include In Waves and War, Of Night and Light: The Story of Iboga and Ibogaine, Swamp Dogg Gets His Pool Painted, When the Smoke Clears, and More

DENVER, May 15, 2025 (GLOBE NEWSWIRE) -- Psychedelic Science – the premier global gathering for psychedelic research, medicine, policy, and culture hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS) – announces Cinematheque: A Celebration of Psychedelic Cinema, a four-day curated film program taking place June 16-19, 2025, in Denver, Colorado as part of Psychedelic Science 2025 (PS2025). Cinematheque will transport audiences into the heart of the psychedelic experience—on screen and beyond.

Cinematheque will explore the profound relationship between film, altered states of consciousness, and the psychedelic movement, offering a dynamic lineup of screenings, filmmaker discussions, and immersive storytelling experiences. From visionary animations and experimental documentaries to in-depth explorations of psychedelic-assisted therapy, this program will highlight the role of cinema in shaping the modern psychedelic renaissance.

Film has long been a portal for exploring consciousness, conveying the ineffable, and sharing stories that challenge and inspire. With the Cinematheque, Psychedelic Science 2025 is bringing together filmmakers, film subjects, creators, and audiences to experience the power of cinema in translating the psychedelic experience into art and narrative.
Lucy Lerner, Cinematheque Curator & Producer, Psychedelic Science 2025

Cinematheque Programming & Featured Screenings

Cinematheque will feature a collection of short film screenings on Monday from 3 p.m. to 5 p.m., followed by a feature film and special presentation starting at 6 p.m., and three daily screening blocks (11 a.m, 3 p.m., 7 p.m.) from Tuesday through Thursday. The program will include approximately 20 films featuring:

  • Feature-length documentaries exploring the science, history, and cultural impact of psychedelics
  • Short films and experimental works that push the boundaries of perception and storytelling
  • Episodic series and works-in-progress offering a glimpse into the future of psychedelic media
  • Exclusive filmmaker Q&As, panel discussions, and interactive screenings

The full schedule and final film list will be announced later this month. Visit psychedelicscience.org to view the full conference schedule, register, and explore hotel and travel options.

Featured Films & Directors

This year’s Cinematheque lineup will showcase visionary directors and groundbreaking films illuminating the psychedelic experience. Select titles include:

  • Dirty Pictures, directed by Étienne Sauret — A deep dive into the life and work of Alexander “Sasha” Shulgin, the chemist behind over 200 psychedelic compounds, including MDMA, examining the tension between scientific innovation and societal boundaries.

  • In Waves and War, directed by Jon Shenk and Bonni Cohen — The emotional journey of a Navy SEAL facing severe PTSD and the breakthrough psychedelic-assisted therapy that offered him a lifeline.

  • SNEAK PEEK: Have a Good Trip 2, directed by Donick Cary — A preview of the sequel to the Netflix documentary on psychedelics, exploring the next 50 years of psychedelic promise and storytelling.

  • John Lilly and the Earth Coincidence Control Office, directed by Courtney Stephens and Michael Almereyda — An essay film exploring consciousness through the radical life and dolphin experiments of psychonaut John C. Lilly.

  • Of Night and Light: The Story of Iboga and Ibogaine, directed by Lucy Walker — A groundbreaking look at the discovery, cultural resistance, and scientific validation of ibogaine as a powerful treatment for addiction and trauma.

  • Patty Are You Bringing Weed in from Jamaica?, directed by Matthew Salton — The 1968 true story of a young flight attendant caught smuggling 900 lbs of marijuana and the wild consequences that follow.

  • Psychedelics: Stepping into the Unknown, directed by Chris Phillips — A world-first clinical psychedelic trial unfolds in Australia, capturing the hopes of participants and the potential for groundbreaking mental health treatments.

  • Santa Is a Psychedelic Mushroom, directed by Matthew Salton — An animated short reimagining Santa Claus through the lens of Arctic shamanism and mushroom folklore.

  • SNEAK PEEK: Prophet of Ecstacy, directed by Elias Varoutsos — The story of Michael Clegg, the former Catholic priest turned MDMA kingpin, tracing the arc of ecstasy through criminalization, spirituality, and cultural resurgence.

  • Spreading the Spores: From Global Stages to Inner Spaces, presented by Louie Schwartzberg — A visionary journey from psychedelic festivals to clinical trials, examining how visual storytelling and psilocybin reshape global consciousness.

  • Swamp Dogg Gets His Pool Painted, directed by Isaac Gale and Ryan Olson — A vibrant portrait of legendary cult musician Swamp Dogg and his artistic household deep in suburban Los Angeles.

  • Psychedelic Puppets, directed by Brad Necyk — A series of surreal shorts featuring puppet-led explorations of psychedelic history and theory, including The Birth of LSD, The Stamets Stack and the Psychedelic Puppets, The Stoned Puppet Theory, and Psychedelic Puppet Show Presents Paul Stamets and Rick Doblin.

  • The Way of the Psychonaut: Stanislav Grof and the Journey of Consciousness, directed by Susan Hess Logeais — A documentary portrait of Stan Grof’s pioneering work in psychedelic therapy and its transformative power.

  • This Is Where I Find Myself, directed by Andrew Hinton — As researcher Roland Griffiths faces terminal cancer, he turns inward using the very psychedelic science he helped bring to the world.

  • Unraveling the Dream: Psychedelics, Meditation, and the Predictive Brain, directed by Jake Orthwein — A sweeping meditation on neuroscience, ego dissolution, and the challenge of building a culture around self-transcendence.

  • When the Smoke Clears, directed by Mischa Schwartz and Maarya Zafar — Two first responders seek psychedelic healing in Mexico after exhausting conventional treatments in the U.S.

  • WILD MAGIC, directed by Sean Dunne — A mystical road trip across America capturing the enchantment and unseen magic in everyday life.

About Psychedelic Science
Psychedelic Science 2025 (PS2025), hosted by the Multidisciplinary Association for Psychedelic Studies (MAPS), is the world’s leading psychedelic conference. Returning to the Colorado Convention Center in Denver from June 16-20, 2025, this five-day event brings together a global community of scientists, therapists, policymakers, cultural leaders, and advocates to explore the forefront of psychedelic research, therapy, and culture. Facilitated by Superfly, known for producing iconic events such as Bonnaroo and Outside Lands, PS2025 will feature expert speakers; hands-on workshops; community events with art, music, and mindfulness activities; and scholarship opportunities to support broad participation.

Since its inception in 2010, the Psychedelic Science conference series has fostered knowledge-sharing, collaboration, and community-building within the psychedelic ecosystem. Join thousands of attendees as we explore the transformative potential of psychedelics and shape the future of mental health, policy, and cultural understanding. For more information and registration details, visit psychedelicscience.org, and follow us on X, Instagram, LinkedIn, and Facebook.

ABOUT MAPS
Founded in 1986, MAPS is a 501(c)(3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS' conference flagship, Psychedelic Science, has been the leading convening of the psychedelic community since 2010. MAPS incubated Lykos Therapeutics, a drug-development public benefit company, and the Zendo Project, a leader in psychedelic harm reduction. Since MAPS was founded, philanthropic donors and grantors have given more than $150 million to advance research, change drug policy, and evolve education in the field of psychedelics.

CONTACT
media@psychedelicscience.org


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.24
-6.19 (-1.29%)
NVDA  178.91
-1.73 (-0.96%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.